Could this ASX 200 share be in for a $1.7 billion boost?

The ASX 200 healthcare stock is reported to be considering selling some high value assets.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) listed Ramsay Health Care Ltd (ASX: RHC) is recovering from the two-year lows its share price hit on 26 September.

That low point came after takeover negotiations with a consortium of financial investors led by KKR failed to reach an agreement.

The ASX 200 healthcare share continued to trade lower over the following days. But the company's share price has rebounded 14% since 28 September. Shares are currently swapping hands for $64.26 apiece.

Some of that lift may be driven by speculation that Ramsay could be planning to sell a goodly portion of its property assets alongside its stake in European hospital operator Ramsay Sante.

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.

Image source: Getty Images

A possible $1.7 billion boost for this ASX 200 stock

Citing unnamed sources close to Ramsay, The Australian reports that it understands the ASX 200 healthcare stock is weighing up selling 25% of its real estate assets.

Ramsay Sante, which operates 210 facilities – including primary care units, specialist clinics, and hospitals in Denmark, Norway, Sweden, and Italy – may also be in the mix.

Should Ramsay Healthcare opt to sell its $1.7 billion majority stake in Ramsay Sante and property assets, Macquarie analysts believe the company's share price could see a healthy boost, improving the stock's return on invested capital.

According to Macquarie (courtesy of The Australian):

Applying a multiple of 12.5 times earnings before interest, tax, depreciation and amortisation for the Australian business, combined with Ramsay Sante sale proceeds, would provide a valuation of about $72.00, 15 per cent ahead of the current share price.

With some recent gains posted by the ASX 200 healthcare company, a $72.00 valuation represents a 12% premium on the share price at the time of writing.

Ramsay share price snapshot

The Ramsay share price has enjoyed a strong month, up almost 14%. That outpaces the 7% monthly gain posted by the ASX 200.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man with rocket wings which have flames coming out of them.
Healthcare Shares

Which ASX All Ords share could rocket 90%?

This stock has caught the eye of analysts at Bell Potter.

Read more »

a smiling picture of legendary US investment guru Warren Buffett.
Healthcare Shares

Would Warren Buffett buy CSL shares?

Would the Sage from Omaha be interested in Australia’s fallen giant?

Read more »

A scientist examining test results.
Healthcare Shares

CSL shares are up 35% since early June. Is the recovery here to stay?

Can CSL shares continue their comeback?

Read more »

patient with doctor, medical company, medical insurance
Healthcare Shares

Where could CSL shares go next? Here's what brokers are predicting

Brokers see long-term value despite differing views on near-term upside.

Read more »

A small child carrying a brief case tries to reach an elevator button outside closed elevator doors.
Healthcare Shares

Up 1,636%, but can 4DMedical shares reclaim their record high?

Can the US growth story drive the ASX star back to records?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Healthcare Shares

Mesoblast shares: Q4 earnings top projections

Ryoncil® uptake has exceeded initial projections

Read more »

A woman leans forward with her hands shielding her eyes as if she is looking intently for something.
Healthcare Shares

Up 36%: Can CSL shares keep rebounding?

Find out what experts expect from CSL shares next.

Read more »

A man looking at his laptop and thinking.
Healthcare Shares

Is CSL a fallen ASX giant to buy in July?

Confidence has been shaken, but I think the long-term opportunity remains attractive.

Read more »